News
PPH
85.14
+0.32%
0.27
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
NASDAQ · 3d ago
Weekly Report: what happened at PPH last week (0408-0412)?
Weekly Report · 5d ago
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
NASDAQ · 5d ago
Weekly Report: what happened at PPH last week (0401-0405)?
Weekly Report · 04/08 11:11
VanEck Pharmaceutical ETF declares quarterly distribution of $0.5328
Seeking Alpha · 04/03 11:19
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328
Seeking Alpha · 04/01 17:18
Weekly Report: what happened at PPH last week (0325-0329)?
Weekly Report · 04/01 11:09
Cons Disc distribution & retail has the highest dispersion among S&P groups - MS
Consumer discretionary distribution & retail has the highest dispersion among S&P groups. Morgan Stanley analysts monitored the dispersion metrics of the S&p 500 and its sectors and subsectors. Dispersion measures the range of returns for a group, Morgan Stanley says. High dispersion present in auto and household, lower in utilities and energy.
Seeking Alpha · 03/26 15:45
Weekly Report: what happened at PPH last week (0318-0322)?
Weekly Report · 03/25 11:11
Thursday's ETF with Unusual Volume: PPH
NASDAQ · 03/21 16:18
Weekly Report: what happened at PPH last week (0311-0315)?
Weekly Report · 03/18 11:10
Weekly Report: what happened at PPH last week (0304-0308)?
Weekly Report · 03/11 11:06
Why Biotech Stocks May Be Ready For A Recovery
Biotech stocks have struggled in recent quarters as high interest rates take a toll on the capital-intensive sector. Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with MoneyTalk's Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a recovery.
Seeking Alpha · 03/09 08:59
Novo Nordisk's Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage
Novo Nordisk A/S’s Wegovy gets approval for expanded use in the U.S. The Danish drugmaker's drug is a weight management therapy for obesity and cardiovascular disease. The FDA approved the drug for a significant reduction in major adverse cardiovascular events. Shares of Novo Nordisk were down 1.9% Friday.
Benzinga · 03/08 19:36
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
NASDAQ · 03/08 11:20
The Top 3 ETFs to Buy in March 2024
Top ETFs to buy offer a smart solution for those looking to diversify their portfolios without the hassle. The Global X Artificial Intelligence & Technology ETF (AIQ) has surged by 45% over the past year. The VanEck Pharmaceutical ETF (PPH) is a fund dedicated to the booming AI industry. Pacer US Cash Cows 100 ETF (COWZ) has a unique focus on free cash flows.
Investorplace · 03/07 18:43
Weekly Report: what happened at PPH last week (0226-0301)?
Weekly Report · 03/04 11:09
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
A small group of European stocks has quietly outperformed most of the world. Goldman Sachs dubbed the group "Granolas" and it accounted for 50% of gains of the Stoxx Europe 600 Index for the past year. Granolas refers to a group of 11 European stocks operating in the healthcare and pharmaceutical sector. The group also includes luxury, consumer staples and software technology companies.
Benzinga · 02/28 19:43
Are Healthcare Stocks A Risky Prescription In A U.S. Election Year?
Seeking Alpha · 02/27 18:15
PJP: Pharma Investing Is Difficult And This Fund Doesn't Make It Easier
Invesco Dynamic Pharmaceuticals ETF is a passively managed fund that tracks the Dynamic Pharmaceutical Intellidex Index. Investing in the pharmaceutical industry is challenging due to the need for specialized knowledge and the industry's underperformance. PJP is overvalued, has lower expected earnings growth, and higher fees compared to its competitors.
Seeking Alpha · 02/27 17:26
More
Webull provides a variety of real-time PPH stock news. You can receive the latest news about VanEck Pharmaceutical ETF through multiple platforms. This information may help you make smarter investment decisions.